Tolerance to bronchodilation during treatment with long-acting beta-agonists, a randomised controlled trial
- Location
-
Deutsche Nationalbibliothek Frankfurt am Main
- ISSN
-
1465-993X
- Extent
-
Online-Ressource
- Language
-
Englisch
- Notes
-
online resource.
- Bibliographic citation
-
Tolerance to bronchodilation during treatment with long-acting beta-agonists, a randomised controlled trial ; volume:6 ; number:1 ; day:16 ; month:9 ; year:2005 ; pages:1-7 ; date:12.2005
Respiratory research ; 6, Heft 1 (16.9.2005), 1-7, 12.2005
- Creator
-
Haney, Sarah
- Contributor
-
Hancox, Robert J.
SpringerLink (Online service)
- DOI
-
10.1186/1465-9921-6-107
- URN
-
urn:nbn:de:1111-201606035473
- Rights
-
Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Last update
-
14.08.2025, 10:48 AM CEST
Data provider
This object is provided by:
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Associated
- Haney, Sarah
- Hancox, Robert J.
- SpringerLink (Online service)
Other Objects (12)
Potential implications of long-acting GLP-1 receptor agonists for critically ill
Add-on Therapy for Symptomatic Asthma despite Long-Acting Beta-Agonists/Inhaled Corticosteroid
Prescribing of long-acting beta-2-agonists/inhaled corticosteroids after the SMART trial
Long-Acting Reversible Contraception
Long-acting beta-agonists in the management of chronic obstructive pulmonary disease: current and future agents
Long-acting olanzapine versus long-acting risperidone for schizophrenia in Spain – a cost-effectiveness comparison
Development of long-acting ARV’s
RETRACTED ARTICLE: Inhaled corticosteroids and long-acting beta-agonists in adult asthma: a winning combination in all?
Creation of a long-acting nanoformulated dolutegravir
Long-acting beta-agonists plus inhaled corticosteroids safety: a systematic review and meta-analysis of non-randomized studies
Risk of active tuberculosis among COPD patients treated with fixed combinations of long-acting beta2 agonists and inhaled corticosteroids
A Network Meta-Analysis of Long-Acting Muscarinic Antagonist (LAMA) and Long-Acting β2-Agonist (LABA) Combinations in COPD
Potential implications of long-acting GLP-1 receptor agonists for critically ill
Add-on Therapy for Symptomatic Asthma despite Long-Acting Beta-Agonists/Inhaled Corticosteroid
Prescribing of long-acting beta-2-agonists/inhaled corticosteroids after the SMART trial
Long-Acting Reversible Contraception
Long-acting beta-agonists in the management of chronic obstructive pulmonary disease: current and future agents
Long-acting olanzapine versus long-acting risperidone for schizophrenia in Spain – a cost-effectiveness comparison
Development of long-acting ARV’s
RETRACTED ARTICLE: Inhaled corticosteroids and long-acting beta-agonists in adult asthma: a winning combination in all?
Creation of a long-acting nanoformulated dolutegravir
Long-acting beta-agonists plus inhaled corticosteroids safety: a systematic review and meta-analysis of non-randomized studies
Risk of active tuberculosis among COPD patients treated with fixed combinations of long-acting beta2 agonists and inhaled corticosteroids
A Network Meta-Analysis of Long-Acting Muscarinic Antagonist (LAMA) and Long-Acting β2-Agonist (LABA) Combinations in COPD
Potential implications of long-acting GLP-1 receptor agonists for critically ill
Add-on Therapy for Symptomatic Asthma despite Long-Acting Beta-Agonists/Inhaled Corticosteroid
Prescribing of long-acting beta-2-agonists/inhaled corticosteroids after the SMART trial
Long-Acting Reversible Contraception
Long-acting beta-agonists in the management of chronic obstructive pulmonary disease: current and future agents
Long-acting olanzapine versus long-acting risperidone for schizophrenia in Spain – a cost-effectiveness comparison
Development of long-acting ARV’s
RETRACTED ARTICLE: Inhaled corticosteroids and long-acting beta-agonists in adult asthma: a winning combination in all?
Creation of a long-acting nanoformulated dolutegravir
Long-acting beta-agonists plus inhaled corticosteroids safety: a systematic review and meta-analysis of non-randomized studies
Risk of active tuberculosis among COPD patients treated with fixed combinations of long-acting beta2 agonists and inhaled corticosteroids